Terms: = Leukemia AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7
3651 results:
1. Application and prognostic relevance of CD34 detection in immunophenotyping of pediatric acute B lymphoblastic leukemia.
Zha W; Yuan Y; Yang T; Zhu LJ; Kong WY; Zhuo JJ
Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3384-3390. PubMed ID: 38766795
[TBL] [Abstract] [Full Text] [Related]
2. Structural studies of intrinsically disordered mll-fusion protein AF9 in complex with peptidomimetic inhibitors.
Yang Y; Ahmad E; Premkumar V; Liu A; Ashikur Rahman SM; Nikolovska-Coleska Z
Protein Sci; 2024 Jun; 33(6):e5019. PubMed ID: 38747396
[TBL] [Abstract] [Full Text] [Related]
3. Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of mll-rearranged cancer cells to WDR5 WIN site inhibition.
Howard GC; Wang J; Rose KL; Jones C; Patel P; Tsui T; Florian AC; Vlach L; Lorey SL; Grieb BC; Smith BN; Slota MJ; Reynolds EM; Goswami S; Savona MR; Mason FM; Lee T; Fesik S; Liu Q; Tansey WP
Elife; 2024 Apr; 12():. PubMed ID: 38682900
[TBL] [Abstract] [Full Text] [Related]
4. Extramedullary infiltration in pediatric acute myeloid leukemia: Results from the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative.
Li W; Shi M; Zhou P; Liu Y; Liu X; Xiao X; Zuo S; Bai Y; Sun K
Pediatr Blood Cancer; 2024 Jul; 71(7):e31014. PubMed ID: 38644612
[TBL] [Abstract] [Full Text] [Related]
5. A rare kmt2a::CBL transcript in an acute monoblastic leukemia patient with an unfavorable outcome.
Yu J; Song F; Zhang M; Xiao P; Feng J; Hong R; Hu Y; Huang H; Wei G
Mol Biol Rep; 2024 Apr; 51(1):561. PubMed ID: 38643442
[TBL] [Abstract] [Full Text] [Related]
6. Characteristics and treatment of acute myeloid neoplasms with cutaneous involvement in infants up to 6 months of age: A retrospective study.
Renaud J; Goemans BF; Locatelli F; Pigazzi M; Redmond S; Kuehni CE; Destaillats A; Alonzo TA; Gerbing RB; Gamis A; Aplenc R; Renella R; Cooper T; Ceppi F
Pediatr Blood Cancer; 2024 Jul; 71(7):e31006. PubMed ID: 38616361
[TBL] [Abstract] [Full Text] [Related]
7. Infant Acute Lymphoblastic leukemia-New Therapeutic Opportunities.
Kulczycka M; Derlatka K; Tasior J; Sygacz M; Lejman M; Zawitkowska J
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612531
[TBL] [Abstract] [Full Text] [Related]
8. Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia.
Yu CH; Su YH; Jou ST; Lu MY; Lin CY; Lin KH; Chang HH; Chou SW; Huang YH; Lin DT; Lin SW; Chen HY; Chang YH; Yang YL
Pathol Res Pract; 2024 Apr; 256():155287. PubMed ID: 38579576
[TBL] [Abstract] [Full Text] [Related]
9. Impact of mll::AF9 Gene Rearrangement on Survival of Acute Myeloid Leukaemia Patients: An Insight into Pakistani Population.
Tariq M; Shahab S; Saeed JR; Hussain Z; Zaidi U; Farzana T; Ahmad S
J Coll Physicians Surg Pak; 2024 Apr; 34(4):424-428. PubMed ID: 38576284
[TBL] [Abstract] [Full Text] [Related]
10. A complex interplay of intra- and extracellular factors regulates the outcome of fetal- and adult-derived mll-rearranged leukemia.
Jassinskaja M; Ghosh S; Watral J; Davoudi M; Claesson Stern M; Daher U; Eldeeb M; Zhang Q; Bryder D; Hansson J
Leukemia; 2024 May; 38(5):1115-1130. PubMed ID: 38555405
[TBL] [Abstract] [Full Text] [Related]
11. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
Wu LX; Zhao MY; Yan N; Zhou YL; Cao LM; Qin YZ; Jiang Q; Xu LP; Zhang XH; Huang XJ; Jiang H; Ruan GR
Clin Exp Med; 2024 Mar; 24(1):56. PubMed ID: 38546916
[TBL] [Abstract] [Full Text] [Related]
12. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
[No Abstract] [Full Text] [Related]
13. Raman spectroscopy can recognize the kmt2a rearrangement as a distinct subtype of leukemia.
Leszczenko P; Nowakowska AM; Jakubowska J; Pastorczak A; Zabczynska M; Mlynarski W; Baranska M; Ostrowska K; Majzner K
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Jun; 314():124173. PubMed ID: 38520957
[TBL] [Abstract] [Full Text] [Related]
14. Loss of RNA-binding protein CELF2 promotes acute leukemia development via FAT10-mTORC1.
Guo T; Wang Y; Sun X; Hou S; Lan Y; Yuan S; Yang S; Zhao F; Chu Y; Ma Y; Cheng T; Yu J; Liu B; Yuan W; Wang X
Oncogene; 2024 May; 43(19):1476-1487. PubMed ID: 38514854
[TBL] [Abstract] [Full Text] [Related]
15. Application of droplet digital PCR in minimal residual disease monitoring of rare fusion transcripts and mutations in haematological malignancies.
Ip BBK; Wong ATC; Law JHY; Au CH; Ma SY; Chim JCS; Liang RHS; Leung AYH; Wan TSK; Ma ESK
Sci Rep; 2024 Mar; 14(1):6400. PubMed ID: 38493200
[TBL] [Abstract] [Full Text] [Related]
16. Regulation of HOX gene expression in AML.
Khan I; Amin MA; Eklund EA; Gartel AL
Blood Cancer J; 2024 Mar; 14(1):42. PubMed ID: 38453907
[TBL] [Abstract] [Full Text] [Related]
17. Bahcc1 is critical for the aberrant epigenetic program in a mouse model of mll-ENL-mediated leukemia.
Nakamura A; Masuya M; Shinmei M; Tawara I; Nosaka T; Ono R
Blood Adv; 2024 May; 8(9):2193-2206. PubMed ID: 38452334
[TBL] [Abstract] [Full Text] [Related]
18. High-dose methotrexate pharmacokinetics and its impact on prognosis of paediatric acute lymphoblastic leukaemia patients: A population pharmacokinetic study.
Chen X; Li J; Yu L; Hu W; Cai J; Wang Z; Chen C; Zhang X; Xie Y; Wu K; Mo Y; Chen J; Shen S
Br J Haematol; 2024 Apr; 204(4):1354-1366. PubMed ID: 38432257
[TBL] [Abstract] [Full Text] [Related]
19. Ferritin-mediated mitochondrial iron homeostasis is essential for the survival of hematopoietic stem cells and leukemic stem cells.
Yi W; Zhang J; Huang Y; Zhan Q; Zou M; Cheng X; Zhang X; Yin Z; Tao S; Cheng H; Wang F; Guo J; Ju Z; Chen Z
Leukemia; 2024 May; 38(5):1003-1018. PubMed ID: 38402368
[TBL] [Abstract] [Full Text] [Related]
20. Discovery of novel pyrrolo[2,3-d]pyrimidines as potent menin-mixed lineage leukemia interaction inhibitors.
Bai H; Yang Z; Lei H; Wu Y; Liu J; Yuan B; Ma M; Gao L; Zhang SQ; Xin M
Eur J Med Chem; 2024 Mar; 268():116226. PubMed ID: 38367493
[TBL] [Abstract] [Full Text] [Related]
[Next]